Impact of 48 weeks of atazanavir/ritonavir plus lamivudine dual therapy on cellular HIV-DNA levels in the AtLaS pilot study

Francesca Lombardi; Simone Belmonti; Massimiliano Fabbiani; Alberto Borghetti; Roberto Cauda; Andrea De Luca; Simona Di Giambenedetto

doi:10.1093/jac/dkw306

Impact of 48 weeks of atazanavir/ritonavir plus lamivudine dual therapy on cellular HIV-DNA levels in the AtLaS pilot study

Francesca Lombardi, Simone Belmonti, Massimiliano Fabbiani, Alberto Borghetti, Roberto Cauda, Andrea De Luca, Simona Di Giambenedetto

Research output: Contribution to journal › Article

2 Citations (Scopus)

Abstract

not available

Original language	English
Pages (from-to)	3621-3622-3622
Journal	Journal of Antimicrobial Chemotherapy
Volume	71
DOIs	https://doi.org/10.1093/jac/dkw306
Publication status	Published - 2016

Keywords

hiv dna, therapy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/jac/dkw306

Cite this

@article{3acf73138ee54f3fb1e7c14583259e72,

title = "Impact of 48 weeks of atazanavir/ritonavir plus lamivudine dual therapy on cellular HIV-DNA levels in the AtLaS pilot study",

abstract = "not available",

keywords = "hiv dna, therapy, hiv dna, therapy",

author = "Francesca Lombardi and Simone Belmonti and Massimiliano Fabbiani and Alberto Borghetti and Roberto Cauda and {De Luca}, Andrea and {Di Giambenedetto}, Simona",

year = "2016",

doi = "10.1093/jac/dkw306",

language = "English",

volume = "71",

pages = "3621--3622--3622",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press:Journals Department, Great Clarendon Street, Oxford OX2 6DP United Kingdom:011 44 1865 556767, EMAIL: [email protected], INTERNET: http://www.oup.co.uk, Fax: 011 44 1865 267485",

}

TY - JOUR

T1 - Impact of 48 weeks of atazanavir/ritonavir plus lamivudine dual therapy on cellular HIV-DNA levels in the AtLaS pilot study

AU - Lombardi, Francesca

AU - Belmonti, Simone

AU - Fabbiani, Massimiliano

AU - Borghetti, Alberto

AU - Cauda, Roberto

AU - De Luca, Andrea

AU - Di Giambenedetto, Simona

PY - 2016

Y1 - 2016

N2 - not available

AB - not available

KW - hiv dna, therapy

UR - http://hdl.handle.net/10807/94850

U2 - 10.1093/jac/dkw306

DO - 10.1093/jac/dkw306

M3 - Article

SN - 0305-7453

VL - 71

SP - 3621-3622-3622

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

ER -

Impact of 48 weeks of atazanavir/ritonavir plus lamivudine dual therapy on cellular HIV-DNA levels in the AtLaS pilot study

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this